3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Sell
16
BEE.CX Quote, Financials, Valuation and Earnings
Last price:
$0.0100
Seasonality move
:
-2.18%
Day range:
$0.0050 - $0.0050
52-week range:
$0.0050 - $0.0500
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.37x
P/B ratio:
0.92x
Volume:
2.1K
Avg. volume:
65.7K
1-year change:
-85.71%
Market cap:
$1M
Revenue:
$601.7K
EPS (TTM):
-$0.02
Analysts' Opinion
-
Consensus RatingBee Vectoring Technologies International has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Bee Vectoring Technologies International has an estimated downside of -- from its current price of $0.0050.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $0.0050.
Fair Value
-
According to the consensus of 0 analysts, Bee Vectoring Technologies International has -- downside to fair value with a price target of -- per share.
BEE.CX vs. S&P 500
-
Over the past 5 trading days, Bee Vectoring Technologies International has underperformed the S&P 500 by -50.78% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Bee Vectoring Technologies International does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Bee Vectoring Technologies International has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Bee Vectoring Technologies International reported revenues of $81.9K.
Earnings Growth
-
Bee Vectoring Technologies International has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Bee Vectoring Technologies International reported earnings per share of $0.00.
Enterprise value:
881.7K
EV / Invested capital:
--
Price / LTM sales:
1.37x
EV / EBIT:
--
EV / Revenue:
1.75x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-1.33x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$276.5K
Return On Assets:
-76.75%
Net Income Margin (TTM):
-725.22%
Return On Equity:
-167.71%
Return On Invested Capital:
-138.99%
Operating Margin:
-477.05%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Income Statement | ||||||
| Revenue | $389.7K | $576.3K | $504K | $360.6K | $81.9K | |
| Gross Profit | $196.3K | $292.9K | $276.5K | $187.9K | $50K | |
| Operating Income | -$4.9M | -$4M | -$4.1M | -$484K | -$390.8K | |
| EBITDA | -$4.6M | -$4.1M | -$3.4M | -$424.2K | $117.6K | |
| Diluted EPS | -$0.04 | -$0.03 | -$0.02 | -$0.00 | $0.00 | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $961.3K | $4.6M | $1.1M | $2.6M | $828.7K | |
| Total Assets | $3M | $6.8M | $3.5M | $5.5M | $3.4M | |
| Current Liabilities | $778K | $441.3K | $788.3K | $1.8M | $1.7M | |
| Total Liabilities | $778K | $612.9K | $938.7K | $2.7M | $2.3M | |
| Total Equity | $2.3M | $6.2M | $2.5M | $2.9M | $1.1M | |
| Total Debt | -- | $124.6K | $150.4K | $549.9K | $301K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$3.3M | -$1.5M | -$662.4K | -$353.4K | $38.2K | |
| Cash From Investing | -$408.4K | -$257.2K | -$240.3K | -$135K | -- | |
| Cash From Financing | $263.3K | $1.3M | $795.3K | $413.9K | -$24.8K | |
| Free Cash Flow | -$3.7M | -$1.8M | -$662.4K | -$488.4K | $38.2K | |
BEE.CX
Sector
Market Cap
$1M
$18.7M
Price % of 52-Week High
10%
59.38%
Dividend Yield
0%
0%
Shareholder Yield
--
1.61%
1-Year Price Total Return
-85.71%
-16.67%
Beta (5-Year)
--
1.056
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$0.0075
200-day SMA
Sell
Level
$0.0164
Bollinger Bands (100)
Sell
Level
0.0111 - 0.0111
Chaikin Money Flow
Sell
Level
-8.9M
20-day SMA
Sell
Level
$0.0083
Relative Strength Index (RSI14)
Sell
Level
43.1576
ADX Line
Sell
Level
10.4947
Williams %R
Buy
Level
-100
50-day SMA
Sell
Level
$0.0084
MACD (12, 26)
Sell
Level
-0.0005
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Sell
Level
-1.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-15.108)
Sell
CA Score
(Annual)
Level (-4.4915)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (10.0604)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Bee Vectoring Technologies International Inc through its subsidiary is focused on the control of pests and enhancement of crops and ornamentals by biological controls in a variety of application processes. Its solution includes The Hive and Bees; and Vectorpak with Vectorite.
Stock Forecast FAQ
In the current month, BEE.CX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BEE.CX average analyst price target in the past 3 months is --.
-
Where Will Bee Vectoring Technologies International Stock Be In 1 Year?
According to analysts, the consensus estimate is that Bee Vectoring Technologies International share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Bee Vectoring Technologies International?
Analysts are divided on their view about Bee Vectoring Technologies International share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bee Vectoring Technologies International is a Sell and believe this share price will rise from its current level to --.
-
What Is Bee Vectoring Technologies International's Price Target?
The price target for Bee Vectoring Technologies International over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BEE.CX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Bee Vectoring Technologies International is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of BEE.CX?
You can purchase shares of Bee Vectoring Technologies International via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bee Vectoring Technologies International shares.
-
What Is The Bee Vectoring Technologies International Share Price Today?
Bee Vectoring Technologies International was last trading at $0.0100 per share. This represents the most recent stock quote for Bee Vectoring Technologies International. Yesterday, Bee Vectoring Technologies International closed at $0.0050 per share.
-
How To Buy Bee Vectoring Technologies International Stock Online?
In order to purchase Bee Vectoring Technologies International stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will American Tower Stock Recover?
The performance of the real estate investment trust, or REIT,…
Will Booking Holdings Stock Split?
Booking Holdings, the travel and technology company that owns brands…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 30.64% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is up 22.41% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is up 18.99% over the past day.
